Therapeutic plasma exchange in neurological disorders: Experience from a tertiary neuroscience centre

Lehmann, 2011, Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies, J Neuroimmunol, 231, 61, 10.1016/j.jneuroim.2010.09.015 Adams, 1952, A method of human plasmapheresis, Proc Soc Exp Biol Med, 80, 377, 10.3181/00379727-80-19629 Pinching, 1976, Remission of myasthenia gravis following plasma-exchange, Lancet, 308, 1373, 10.1016/S0140-6736(76)91917-6 Newsom-Davis, 1978, Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange, Neurology, 28, 266, 10.1212/WNL.28.3.266 Schmidt, 2018, Therapeutic plasma exchange in a tertiary care center: 185 patients undergoing 912 treatments - a one-year retrospective analysis, BMC Nephrol, 19, 12, 10.1186/s12882-017-0803-3 Yeh, 2001, Therapeutic apheresis in Taiwan, Ther Apher Dial, 5, 513, 10.1046/j.1526-0968.2001.00353.x Arslan, 2004, Therapeutic plasma exchange in a single center: ibni Sina experience, Transfus Apher Sci, 30, 181, 10.1016/j.transci.2004.02.007 Tazi, 2008, Therapeutic plasma exchange in Casablanca, Transfus Apher Sci, 39, 45, 10.1016/j.transci.2008.05.009 Schwartz, 2013, Guidelines on the use of therapeutic apheresis in clinical practice-evidence-Based approach from the writing committee of the American Society for Apheresis: the sixth special issue, J Clin Apher, 28, 145, 10.1002/jca.21276 Vucic, 1998, Safety of plasmapheresis in the treatment of neurological disease, Aust N Z J Med, 28, 301, 10.1111/j.1445-5994.1998.tb01952.x Kaynar, 2008, Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study, Transfus Apher Sci, 38, 109, 10.1016/j.transci.2007.11.002 Brunetta Gavranić, 2011, Changes in indications for therapeutic plasma exchange over the last 27 years in Croatia, Ther Apher Dial, 15, 587, 10.1111/j.1744-9987.2011.00986.x Yücesan, 2007, Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases, Transfus Apher Sci, 36, 103, 10.1016/j.transci.2006.06.008 Kaya, 2013, Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis, Transfus Apher Sci, 48, 349, 10.1016/j.transci.2013.04.015 Tombak, 2017, Therapeutic plasma exchange in patients with neurologic disorders: review of 63 cases, Indian J Hematol Blood Transfus, 33, 97, 10.1007/s12288-016-0661-3 Sinanović, 2017, Plasmapheresis in neurological disorders: six years experience from University Clinical center Tuzla, F1000Research, 6, 1234, 10.12688/f1000research.11841.1 Gafoor, 2014, Plasmapheresis in neurological disorders: experience from a tertiary care hospital in South India, Ann Indian Acad Neurol, 18, 15 Cid, 2014, Efficacy and safety of plasma exchange: an 11-year single-center experience of 2730 procedures in 317 patients, Transfus Apher Sci, 51, 209, 10.1016/j.transci.2014.08.018 Basic-Jukic, 2010, Plasma exchange in elderly patients, Ther Apher Dial, 14, 161, 10.1111/j.1744-9987.2009.00793.x 1997, Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group, Lancet (London, England), 349, 225, 10.1016/S0140-6736(96)09095-2 Sedal, 2017, Current concepts in multiple sclerosis therapy, Degener Neurol Neuromuscul Dis, 7, 109 Vincent, 2004, Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitis, Brain, 127, 701, 10.1093/brain/awh077 Sadalage, 2016, Use of plasma exchange for neurological indications, J Neurol Neurosurg Psychiatry, 87, 10.1136/jnnp-2016-315106.156 Zinman, 2008, IVIG treatment for myasthenia gravis, Ann N Y Acad Sci, 1132, 264, 10.1196/annals.1405.038 Lennon, 2005, IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel, J Exp Med, 202, 473, 10.1084/jem.20050304 Stegmayr, 2008, World apheresis registry 2003–2007 data, Transfus Apher Sci, 39, 247, 10.1016/j.transci.2008.09.003 Henze, 1990, Complications of plasma exchange in patients with neurological diseases, Klin Wochenschr, 68, 1183, 10.1007/BF01815277 Buckley, 2001, Potassium channel antibodies in two patients with reversible limbic encephalitis, Ann Neurol, 50, 73, 10.1002/ana.1097 Dalmau, 2007, Paraneoplastic anti- N -methyl-D-aspartate receptor encephalitis associated with ovarian teratoma, Ann Neurol, 61, 25, 10.1002/ana.21050 Wong, 2010, An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis, J Neurol Neurosurg Psychiatry, 81, 1167, 10.1136/jnnp.2009.178293 Zhang, 2017, Clinical characteristics, treatments, and outcomes of patients with anti- N -methyl- d -aspartate receptor encephalitis: a systematic review of reported cases, Epilepsy Behav, 68, 57, 10.1016/j.yebeh.2016.12.019 Lancaster, 2016, The diagnosis and treatment of autoimmune encephalitis, J Clin Neurol, 12, 1, 10.3988/jcn.2016.12.1.1 Rosenfeld, 2014, Antibody-mediated central nervous system diseases: disease recognition and treatment challenges, Clin Exp Immunol, 178, 30, 10.1111/cei.12501 Rodnitzky, 1982, Complications of plasma exchange in neurological patients, Arch Neurol, 39, 350, 10.1001/archneur.1982.00510180028007 Cortina, 2017, Therapeutic plasma exchange in children: one center’s experience, J Clin Apher, 32, 494, 10.1002/jca.21547